Skip to main content
. 2020 Sep 3;35(11):3254–3261. doi: 10.1007/s11606-020-06119-z

Table 3.

Nudge Activation

Nudge
Tailored Advisory Refill Protocol Lab Result Preference List (metformin) Preference List (non-metformin)
Activations Total 3192 2332 3445 213 360
Unique providers 60 70 73 43 47
Unique patients 1033 796 813 189 272
Breakdown by number of unique patients
Location Vanguard 1 121 (11.7%) 89 (11.2%) 92 (11.3%) Patient-level data was not collected for the Preference List nudge.
Vanguard 2 220 (21.3%) 164 (20.6%) 167 (20.5%)
Pilot 1 131 (12.7%) 116 (14.6%) 95 (11.7%)
Pilot 2 220 (21.3%) 192 (24.1%) 195 (24.0%)
Pilot 3 341 (33.0%) 235 (29.5%) 264 (32.5%)
Gender Female 604 (58.5%) 466 (58.5%) 475 (58.4%)
Age range 76–79 years 332 (32.1%) 265 (33.3%) 268 (33.0%)
80–89 years 606 (58.7%) 461 (57.9%) 483 (59.4%)
90–99 years 93 (9.0%) 69 (8.7%) 62 (7.6%)
100+ years 2 (0.2%) 1 (0.1%) 0 (0%)
LE High 676 (65.4%) 541 (68.0%) 528 (64.9%)
Medium 343 (33.2%) 245 (30.8%) 271 (33.3%)
Low 14 (1.4%) 10 (1.3%) 14 (1.7%)
Medication status Metformin alert 534 (51.7%) 359 (45.1%) 475 (58.4%)
Non-metformin alert 499 (48.3%) 437 (54.9%) 338 (41.6%)
Provider feedback Comments 126 total (109 unique patients) 0 N/A

(Top half) Frequency of activation of nudges #1 through #4 from June 12, 2018 (date of earliest nudge activation), through October 17, 2019. Counts are provided in total and by the number of unique providers and patients who received each alert. The Preference List is further stratified by orders placed for metformin or non-metformin medications within Epic. (Bottom half) Stratification of the number of unique patients who received nudges #1 through #3 by practice location, gender, age range, LE categorization, whether the patient received a metformin or non-metformin–based medication alert, and number of comments left by providers